As Humira biosim sales languish, Boehringer Ingelheim plots layoffs in pivot to hybrid marketing model

5th April 2024 Uncategorised 0

As Humira biosim sales languish, Boehringer Ingelheim plots layoffs in pivot to hybrid marketing model
fkansteiner
Fri, 04/05/2024 – 11:07

More: As Humira biosim sales languish, Boehringer Ingelheim plots layoffs in pivot to hybrid marketing model
Source: fierce